BioCardia, Inc. (NASDAQ:BCDA) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the BioCardia Third Quarter 2024 Financial Results and Business Update Conference Call.
Biocardia Inc. (BCDA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.22 | 250 | Officer, Director | 105,581 | 2024-12-05 | Filing | |
| $1.87 | 1,350 | Officer, Director | 105,331 | 2024-11-15 | Filing | |
| $3.05 | 300 | Officer, Director | 39,745 | 2024-07-01 | Filing | |
| $2.99 | 200 | Officer, Director | 39,445 | 2024-06-28 | Filing | |
| $3.29 | 500 | Officer, Director | 39,245 | 2024-06-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.43 | 129,802 | Large Shareholder | 1,896,025 | 2024-01-19 | Filing | |
| $2.31 | 3,200 | Officer, Director | 203,200 | 2020-11-27 | Filing | |
| $2.01 | 8,435 | Officer | 12,088 | 2020-11-02 | Filing | |
| $0.13 | 19,230,769 | Large Shareholder | 130,503,835 | 2016-12-21 | Filing | |
| $0.10 | 872,205 | Director | 0 | 2016-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 46,666.666,666,667 | $464,940 | 0.37% | |
| 2. | 43,384.2 | $432,237 | 0% | |
| 3. | 10,643.2 | $106,038 | 0% | |
| 4. | 9,953.3,333,333,333 | $98,538 | 0% | |
| 5. | 5,166.6,666,666,667 | $51,476 | 0.01% |
News See All
BioCardia, Inc. (NASDAQ:BCDA) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon. And welcome to the BioCardia Second Quarter 2024 Financial Results and Business Update Conference Call.
BioCardia, Inc. (NASDAQ:BCDA) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the BioCardia First Quarter 2024 Financial Results and Business Update Conference Call.
Insiders Are Buying These 11 Penny Stocks
US stock market started the second quarter of 2024 in the red, driven by rising treasury yields, broader volatility and uncertainty around rate cuts as inflation remains sticky.
BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.
BioCardia, Inc. (NASDAQ:BCDA) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to the BioCardia 2023 Third Quarter Conference Call. At this time, all participants are in a listen-only mode.
BioCardia, Inc. (NASDAQ:BCDA) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2023 Second Quarter Conference Call. At this time, all participants are in a listen-only mode.
BioCardia, Inc. (NASDAQ:BCDA) Q1 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2023 First Quarter Conference Call.
BioCardia, Inc. (NASDAQ:BCDA) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2022 Yearend Conference Call. At this time, all participants are in a listen-only mode.
Is BioCardia, Inc. (BCDA) A Good Stock To Buy?
In this article you are going to find out whether hedge funds think BioCardia, Inc. (NASDAQ:BCDA) is a good investment right now.
Billionaire Hedge Funds
